Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy

Area of Science:

• Neuropathology
• Neurodegenerative Diseases
• Cerebrovascular Diseases

Background:

• Cerebral amyloid angiopathy (CAA) is a common cause of lobar intracerebral hemorrhage (ICH) in the elderly, driven by beta-amyloid (Aβ) protein deposition in cerebrovasculature.
• CAA is frequently observed in Alzheimer's disease (AD) patients and independently contributes to cognitive decline.
• Specific apolipoproteins (Apo) are implicated in Aβ fibrillization and clearance, suggesting a role in CAA pathogenesis.

Purpose of the Study:

• To investigate the differential distribution patterns of apolipoproteins E (ApoE), A-I (ApoA-I), and J/clusterin (ApoJ) in autopsy brains.
• To correlate apolipoprotein brain levels with distinct cerebral amyloid angiopathy (CAA) pathological presentations, including vascular and parenchymal Aβ deposits.
• To examine the association between apolipoprotein profiles, APOE genotype, and the occurrence of intracerebral hemorrhage (ICH) in CAA patients.

Main Methods:

• Analysis of brain tissue from 20 post-mortem cases with varying CAA types (Type I, Type II) and Aβ deposit presence.
• Quantification and immunohistochemical localization of ApoE, ApoA-I, and ApoJ protein expression.
• Adjustment of protein expression levels by APOE genotype and statistical analysis to identify independent predictors of ICH.

Main Results:

• ApoE and ApoJ were abundant in meningeal, cortical, and capillary vessels with vascular Aβ accumulation, and also deposited in the parenchyma with diffuse and neuritic Aβ deposits.
• ApoA-I staining was primarily observed in capillary walls, notably in CAA Type I cases.
• Intracerebral hemorrhage (ICH) was the main cause of death in the CAA cohort; ICH patients more frequently carried the APOEε2 allele and exhibited higher vascular ApoE levels. Higher ApoE in cortical arteries independently predicted ICH.

Conclusions:

• ApoE and ApoJ are significantly involved in both vascular and parenchymal Aβ pathology in CAA.
• ApoA-I appears specifically associated with CAA, particularly CAA Type I pathology.
• This study provides molecular insights into the distribution subtypes of Aβ deposition in the brain, highlighting ApoE as a key predictor of ICH in CAA.